trihexyphenidyl has been researched along with Auditory Processing Disorder, Central in 1 studies
Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Focal dystonia of the right hand and speech impairment as a result of a circumscribed left-sided anterior thalamic lesion is reported in a 9-year-old girl with borderline normal psychomotor development." | 1.29 | Focal dystonia and speech impairment responding to anticholinergic therapy. ( Maassen, B; Merx, JL; Rotteveel, JJ; Vogels, OJ, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vogels, OJ | 1 |
| Maassen, B | 1 |
| Rotteveel, JJ | 1 |
| Merx, JL | 1 |
1 other study available for trihexyphenidyl and Auditory Processing Disorder, Central
| Article | Year |
|---|---|
Focal dystonia and speech impairment responding to anticholinergic therapy.
Topics: Cerebral Infarction; Child; Dystonia; Female; Humans; Language Development Disorders; Language Tests | 1994 |